ghk cu dosing safety GHK-Cu Peptide Guide: Skin, Hair & (2026) What are the recommended dosing

These naturally occurring compounds have excellent biocompatibility with minimal risk of adverse reactions

10.1073/pnas.1415174111 67 LeeB.MoonK

Some are generally considered safe to use while others are available for research use only

Key Takeaways Gastrointestinal events are the most common adverse effects: Nausea, diarrhea, and vomiting were reported in 4067% of participants at higher doses in published Phase 2 trial data Adverse events are dose-dependent: Higher retatrutide doses consistently produced higher rates of GI events across all published trials Most adverse events were mild to moderate: The Phase 2 trial reported the majority of events as Grade 1-2 in severity Discontinuation rates ranged from 610%: Published data shows dropout rates due to adverse events were comparable to other GLP-1 class compounds Retatrutide is not FDA-approved: All safety data comes from investigational clinical trials it remains a research compound What Clinical Trials Tell Us About Retatrutide Adverse Events Retatrutide (LY3437943) is an investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously

Maintaining adequate levels to support your health at the cellular level helps you feel your best